Arzneimittelforschung · 2011 · 16 citations · 0 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryPain MedicineSynthetic Medicinal ChemistryAnalgesiaAnalgesic PharmacologyAnti-inflammatory PharmacologyGastrointestinal PharmacologyInflammation PharmacologyAnalgesic Drug DevelopmentAnti-inflammatory ActivityAnti-inflammatory TherapeuticsChronic Inflammatory Disease ModelsPharmacological ScreeningQuinoline SynthesisQuinoxaline ChemistryQuinoxaline Synthesis
Some new substituted quinoxaline and furo[2,3-b]quinoxaline derivatives have been synthesized and tested for their anti-inflammatory and analgesic activities and for their ulcerogenic potential. The pharmacological evaluation of selected synthesized compounds revealed that 5a was equipotent and compounds 3, 4b, 4e and 5b possessed strong anti-inflammatory activity in chronic inflammatory models compared with indometacin (CAS 53-86-1) as reference drug. In addition, compound 4a was the safest one and the others showed little ulcerogenic activity. All the tested compounds showed moderate analgesic activity compared to the reference drug.